Geron: FDA delays 1st trial of stem cell treatment

August 18, 2009

The company plans to start testing its product on humans this summer, but that testing will be delayed during the FDA’s review. Geron said it will work with the FDA, and did not estimate how long the review will take. (The Associated Press)